Moguisteine
Alternative Names: BBR 2173Latest Information Update: 07 Feb 2001
At a glance
- Originator Roche
- Class Antitussives; Small molecules; Thiazolidines
- Mechanism of Action Cholinergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cough
Most Recent Events
- 07 Feb 2001 Discontinued-preregistration for Cough in Italy (PO)
- 13 Oct 1998 Recordati has an agreement with Boehringer Mannheim to supply industrial quantities of moguisteine
- 10 Jun 1997 Preregistration for Cough in Italy (PO)